Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Convergent evidence linking neonatal vitamin D status and risk of neurodevelopmental disorders: a Danish case-cohort study.

Horsdal HT. et al, (2025), Lancet Psychiatry, 12, 410 - 420

Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations.

Perkins DO. et al, (2025), Schizophrenia (Heidelb), 11

Sex-stratified genome-wide association meta-analysis of Major Depressive Disorder.

Thomas JT. et al, (2025)

Familial coaggregation and shared familiality of functional and internalizing disorders in the Lifelines cohort.

Bos M. et al, (2025), Psychol Med, 55

Improving Outcomes in Mental Health (IOMH)-an Australian longitudinal clinical study of families with children with neurodevelopmental problems: cohort profile.

Galligan DE. et al, (2025), BMJ Open, 15

Mental health and sleep correlates of self-reported outdoor daylight exposure in over 13,000 adults with depression.

Crouse JJ. et al, (2025), Eur Psychiatry, 1 - 34

Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies.

Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Electronic address: andrew.mcintosh@ed.ac.uk None. and Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium None., (2025), Cell, 188, 640 - 652.e9

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

Wei D. et al, (2025), EBioMedicine, 113

Grey-Matter Structure Markers of Alzheimer's Disease, Alzheimer's Conversion, Functioning and Cognition: A Meta-Analysis Across 11 Cohorts.

Couvy-Duchesne B. et al, (2025), Hum Brain Mapp, 46

Connecting genomic results for psychiatric disorders to human brain cell types and regions reveals convergence with functional connectivity.

Yao S. et al, (2025), Nat Commun, 16

Applying Machine-Learning and Deep-Learning to Predict Depression from Brain MRI and Identify Depression-Related Brain Biology

Jiang JC. et al, (2025)

Genome-wide meta-analyses of non-response to antidepressants identify novel loci and potential drugs.

Koch E. et al, (2024), Res Sq

Extensive antagonistic variants across human genome

Bian B. et al, (2024)

Sex-Specific Association Between Genetic Risk of Psychiatric Disorders and Cardiovascular Diseases.

Jiang J-C. et al, (2024), Circ Genom Precis Med

Genome-wide copy number variation association study in anorexia nervosa.

Walker A. et al, (2024), Mol Psychiatry

Antidepressant switching as a proxy phenotype for drug non-response: investigating clinical, demographic and genetic characteristics

Lo CWH. et al, (2024)

Changes in sleep patterns in people with a history of depression during the COVID-19 pandemic: a natural experiment.

Shin M. et al, (2024), BMJ Ment Health, 27

F58. COHORT PROFILE: IMPROVING OUTCOMES OF MENTAL HEALTH (IOMH) A LONGITUDINAL CLINICAL STUDY OF FAMILIES WITH CHILDREN WITH NEURODEVELOPMENTAL PROBLEMS

Galligan D. et al, (2024), European Neuropsychopharmacology, 87, 236 - 237

GENOME-WIDE FINE-MAPPING IMPROVES IDENTIFICATION OF CAUSAL VARIANTS

Zeng J. et al, (2024), European Neuropsychopharmacology, 87, 12 - 13

LATEST INSIGHTS FROM MULTI-ANCESTRY FINE-MAPPING IN PSYCHIATRIC DISORDERS

Koromina M. and Wray N., (2024), European Neuropsychopharmacology, 87, 11 - 11

Load More

Include forthcoming?